BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35453608)

  • 1. COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility.
    Goebel H; Koeditz B; Huerta M; Kameri E; Nestler T; Kamphausen T; Friemann J; Hamdorf M; Ohrmann T; Koehler P; Cornely OA; Montesinos-Rongen M; Nicol D; Schorle H; Boor P; Quaas A; Pallasch C; Heidenreich A; von Brandenstein M
    Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular origin of microRNA-371a-3p in healthy males based on systematic urogenital tract tissue evaluation.
    Boellaard WPA; Gillis AJM; van Leenders GJLH; Stoop H; van Agthoven T; Dorssers LCJ; Dinkelman-Smit M; Boormans JL; Looijenga LHJ
    Andrology; 2019 Jul; 7(4):463-468. PubMed ID: 30786164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor.
    Belge G; Hennig F; Dumlupinar C; Grobelny F; Junker K; Radtke A; Dieckmann KP
    Oncotarget; 2020 Apr; 11(16):1462-1473. PubMed ID: 32363003
    [No Abstract]   [Full Text] [Related]  

  • 4. CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males.
    Spiller CM; Lobo J; Boellaard WPA; Gillis AJM; Bowles J; Looijenga LHJ
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32210110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP
    Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
    Syring I; Bartels J; Holdenrieder S; Kristiansen G; Müller SC; Ellinger J
    J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.
    Badia RR; Abe D; Wong D; Singla N; Savelyeva A; Chertack N; Woldu SL; Lotan Y; Mauck R; Ouyang D; Meng X; Lewis CM; Majmudar K; Jia L; Kapur P; Xu L; Frazier AL; Margulis V; Strand DW; Coleman N; Murray MJ; Amatruda JF; Lafin JT; Bagrodia A
    J Urol; 2021 Jan; 205(1):137-144. PubMed ID: 32856980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of miRNA-371a-3p in seminal plasma and ejaculate is associated with sperm concentration.
    Radtke A; Dieckmann KP; Grobelny F; Salzbrunn A; Oing C; Schulze W; Belge G
    Andrology; 2019 Jul; 7(4):469-474. PubMed ID: 31310058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of plasma miR-371a-3p in germ cell tumors.
    Mego M; van Agthoven T; Gronesova P; Chovanec M; Miskovska V; Mardiak J; Looijenga LHJ
    J Cell Mol Med; 2019 Feb; 23(2):1128-1136. PubMed ID: 30536846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
    Lobo J; Leão R; Gillis AJM; van den Berg A; Anson-Cartwright L; Atenafu EG; Kuhathaas K; Chung P; Hansen A; Bedard PL; Jewett MAS; Warde P; O'Malley M; Sweet J; Looijenga LHJ; Hamilton RJ
    Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence.
    Christiansen AJ; Lobo J; Fankhauser CD; Rothermundt C; Cathomas R; Batavia AA; Grogg JB; Templeton AJ; Hirschi-Blickenstorfer A; Lorch A; Gillessen S; Moch H; Beyer J; Hermanns T
    Front Oncol; 2022; 12():1056823. PubMed ID: 36568207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.
    Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G
    Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis.
    Piao J; Lafin JT; Scarpini CG; Nuño MM; Syring I; Dieckmann KP; Belge G; Ellinger J; Amatruda JF; Bagrodia A; Coleman N; Krailo MD; Frazier AL; Murray MJ
    Clin Genitourin Cancer; 2021 Dec; 19(6):469-479. PubMed ID: 34629299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
    Radtke A; Cremers JF; Kliesch S; Riek S; Junker K; Mohamed SA; Anheuser P; Belge G; Dieckmann KP
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2383-2392. PubMed ID: 28819887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours.
    Fankhauser CD; Christiansen AJ; Rothermundt C; Cathomas R; Wettstein MS; Grossmann NC; Grogg JB; Templeton AJ; Hirschi-Blickenstorfer A; Lorch A; Gillessen S; Moch H; Beyer J; Hermanns T
    Br J Cancer; 2022 May; 126(8):1140-1144. PubMed ID: 34912073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Hypermethylated
    Lobo J; van Zogchel LMJ; Nuru MG; Gillis AJM; van der Schoot CE; Tytgat GAM; Looijenga LHJ
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors.
    Murray MJ; Ajithkumar T; Harris F; Williams RM; Jalloh I; Cross J; Ronghe M; Ward D; Scarpini CG; Nicholson JC; Coleman N
    Neurooncol Adv; 2020; 2(1):vdaa048. PubMed ID: 32642701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-RNA-371a-3p in Germ Cell Testicular Tumors on Diagnosis: A Prospective Case-Control Study in Turkish Population.
    Kılınç MT; Göger YE; Özkent MS; Kılıç Ö; Okur Altındaş B; Yıldırım MS; Karalezli G
    Urol J; 2024 Apr; ():. PubMed ID: 38629199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germ cell tumour subtypes display differential expression of microRNA371a-3p.
    Vilela-Salgueiro B; Barros-Silva D; Lobo J; Costa AL; Guimarães R; Cantante M; Lopes P; Braga I; Oliveira J; Henrique R; Jerónimo C
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid.
    Dieckmann KP; Spiekermann M; Balks T; Ikogho R; Anheuser P; Wosniok W; Loening T; Bullerdiek J; Belge G
    Urol Int; 2016; 97(1):76-83. PubMed ID: 26989896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.